Fortress Biotech Stock Forecast, Price & News

Fortress Biotech (NASDAQ:FBIO) Frequently Asked Questions

Is Fortress Biotech a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fortress Biotech in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Fortress Biotech stock.
View analyst ratings for Fortress Biotech or view top-rated stocks.

How has Fortress Biotech's stock been impacted by Coronavirus?

Fortress Biotech's stock was trading at $1.61 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FBIO shares have increased by 27.3% and is now trading at $2.05.
View which stocks have been most impacted by COVID-19.

Are investors shorting Fortress Biotech?

Fortress Biotech saw a increase in short interest in December. As of December 31st, there was short interest totaling 856,700 shares, an increase of 16.4% from the December 15th total of 735,700 shares. Based on an average trading volume of 413,700 shares, the short-interest ratio is currently 2.1 days. Approximately 1.2% of the company's stock are short sold.
View Fortress Biotech's Short Interest.

When is Fortress Biotech's next earnings date?

Fortress Biotech is scheduled to release its next quarterly earnings announcement on Wednesday, March 30th 2022.
View our earnings forecast for Fortress Biotech.

How were Fortress Biotech's earnings last quarter?

Fortress Biotech, Inc. (NASDAQ:FBIO) posted its quarterly earnings results on Monday, November, 15th. The biopharmaceutical company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.08) by $0.06. The biopharmaceutical company had revenue of $21.09 million for the quarter, compared to analysts' expectations of $18.41 million. Fortress Biotech had a negative trailing twelve-month return on equity of 17.04% and a negative net margin of 59.81%.
View Fortress Biotech's earnings history.

What price target have analysts set for FBIO?

6 brokers have issued 12 month price targets for Fortress Biotech's stock. Their forecasts range from $5.00 to $21.00. On average, they anticipate Fortress Biotech's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 524.4% from the stock's current price.
View analysts' price targets for Fortress Biotech or view top-rated stocks among Wall Street analysts.

Who are Fortress Biotech's key executives?

Fortress Biotech's management team includes the following people:

• Lindsay Allan Rosenwald, Chairman, President & Chief Executive Officer
• Robyn M. Hunter, Chief Financial Officer, Secretary & Treasurer
• George C. Avgerinos, Senior Vice President-Biologics Operations
• Michael Sean Weiss, Director & Vice Chairman-Strategic Development
• Brian Achenbach, Vice President-Finance & Controller

Who are some of Fortress Biotech's key competitors?

Some companies that are related to Fortress Biotech include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Exact Sciences (EXAS), Repligen (RGEN), United Therapeutics (UTHR), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Arena Pharmaceuticals (ARNA).
View all of FBIO's competitors.

What other stocks do shareholders of Fortress Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fortress Biotech investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Novavax (NVAX), Advanced Micro Devices (AMD), OPKO Health (OPK), TG Therapeutics (TGTX), Vaxart (VXRT), NVIDIA (NVDA), Pfizer (PFE) and Dynavax Technologies (DVAX).

What is Fortress Biotech's stock symbol?

Fortress Biotech trades on the NASDAQ under the ticker symbol "FBIO."

Who are Fortress Biotech's major shareholders?

Fortress Biotech's stock is owned by many different retail and institutional investors. Top institutional investors include Shikiar Asset Management Inc. (0.71%), Russell Investments Group Ltd. (0.03%) and Cutler Group LP (0.00%). Company insiders that own Fortress Biotech stock include Eric K Rowinsky, Lindsay A Md Rosenwald, Malcolm Hoenlein and Robyn Hunter.
View institutional ownership trends for Fortress Biotech.

Which major investors are selling Fortress Biotech stock?

FBIO stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd..
View insider buying and selling activity for Fortress Biotech or view top insider-selling stocks.

Which major investors are buying Fortress Biotech stock?

FBIO stock was purchased by a variety of institutional investors in the last quarter, including Shikiar Asset Management Inc., and Cutler Group LP. Company insiders that have bought Fortress Biotech stock in the last two years include Lindsay A Md Rosenwald, and Malcolm Hoenlein.
View insider buying and selling activity for Fortress Biotech or or view top insider-buying stocks.

How do I buy shares of Fortress Biotech?

Shares of FBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fortress Biotech's stock price today?

One share of FBIO stock can currently be purchased for approximately $2.05.

How much money does Fortress Biotech make?

Fortress Biotech has a market capitalization of $204.24 million and generates $45.60 million in revenue each year. The biopharmaceutical company earns $-46.53 million in net income (profit) each year or ($0.47) on an earnings per share basis.

How many employees does Fortress Biotech have?

Fortress Biotech employs 111 workers across the globe.

What is Fortress Biotech's official website?

The official website for Fortress Biotech is www.fortressbiotech.com.

Where are Fortress Biotech's headquarters?

Fortress Biotech is headquartered at 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014.

How can I contact Fortress Biotech?

Fortress Biotech's mailing address is 2 GANSEVOORT STREET 9TH FLOOR, NEW YORK NY, 10014. The biopharmaceutical company can be reached via phone at (781) 652-4500, via email at [email protected], or via fax at 781-652-4545.